Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide

PURPOSE: A substantial number of ischaemic stroke patients who receive reperfusion therapy in the acute phase do not ever fully recover. This reveals the urgent need to develop new adjunctive neuroprotective treatment strategies alongside reperfusion therapy. Previous experimental studies demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Basalay, Maryna V., Davidson, Sean M., Yellon, Derek M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994526/
https://www.ncbi.nlm.nih.gov/pubmed/31721014
http://dx.doi.org/10.1007/s10557-019-06915-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994526/
https://www.ncbi.nlm.nih.gov/pubmed/31721014
http://dx.doi.org/10.1007/s10557-019-06915-8

Ejemplares similares